Future studies will be required to obtain a better understanding of the molecular and cellular mechanisms involved in the regulation of OE homeostasis by neurotrophic factors and insulin receptor signaling, as well as to elucidate the pharmacokinetics of insulin in the nasal mucus, to assess the potential for the development of novel therapeutic agents for CRS-related olfactory dysfunction. This evidence concerns the gene INSR and congenital rubella syndrome.